UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000043423
Receipt number R000049575
Scientific Title Study with the transparent bandage on intravenous feeding fixation of children
Date of disclosure of the study information 2021/04/01
Last modified on 2024/03/01 09:44:06

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Study with the transparent bandage on intravenous feeding fixation of children

Acronym

Study with the transparent bandage on intravenous feeding fixation of children

Scientific Title

Study with the transparent bandage on intravenous feeding fixation of children

Scientific Title:Acronym

Study with the transparent bandage on intravenous feeding fixation of children

Region

Japan


Condition

Condition

Extravasation

Classification by specialty

Child

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

Reduce the risk of delayed detection of extravascular leakage and the severity of symptoms.

Basic objectives2

Safety

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Early detection of extravascular leakage

Key secondary outcomes

Complications such as allergies


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification

NO

Dynamic allocation

NO

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Fix the IV with a transparent bandage as in conventional splint fixation. In order to enable nurses and ICU physicians to prevent serious cases of extravascular leakage of IVs, it should be confirmed that the IV fixation area can be easily observed compared to conventional seine fixation. In addition, we will evaluate the method of fixation with transparent bandages in terms of safety, stress, and cleanliness.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

1 days-old <=

Age-upper limit

15 years-old >

Gender

Male and Female

Key inclusion criteria

Patient in intensive care unit

Key exclusion criteria

with skin diseases, infections or wounds on the skin

Target sample size

100


Research contact person

Name of lead principal investigator

1st name Manabu
Middle name
Last name Kitano

Organization

Osaka Medical and Pharmaceutical University

Division name

Intensive Care Unit

Zip code

569-8686

Address

2-7 Daigaku-machi, Takatsuki,Osaka, Japan

TEL

072-683-1221

Email

manabu.kitano@ompu.ac.jp


Public contact

Name of contact person

1st name Manabu
Middle name
Last name Kitano

Organization

Osaka Medical and Pharmaceutical University

Division name

Intensive Care Unit

Zip code

569-8686

Address

2-7 Daigaku-machi, Takatsuki,Osaka, Japan

TEL

072-683-1221

Homepage URL


Email

manabu.kitano@ompu.ac.jp


Sponsor or person

Institute

Osaka Medical and Pharmaceutical University

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Osaka Medical and Pharmaceutical University

Address

2-7 Daigaku-machi, Takatsuki,Osaka, Japan

Tel

072-683-1221

Email

manabu.kitano@ompu.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

大阪医科薬科大学


Other administrative information

Date of disclosure of the study information

2021 Year 04 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2021 Year 02 Month 12 Day

Date of IRB

2021 Year 05 Month 10 Day

Anticipated trial start date

2021 Year 04 Month 01 Day

Last follow-up date

2026 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 02 Month 24 Day

Last modified on

2024 Year 03 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000049575


Research Plan
Registered date File name
2023/09/25 【様式2】研究計画書0224.docx

Research case data specifications
Registered date File name

Research case data
Registered date File name